ACRO & TransCelerate Issue a Joint Statement on Considerations while Developing Clinical Study Reports (CSRs)
Our member companies have faced widespread clinical trial disruptions in the past few years – from the global pandemic, to the war in Ukraine. We developed a recommendation for how sponsors and CROs should report study disruptions in a Clinical Study Report (CSR).
Click Here to Read the Considerations Statement
Loading...
Reload document
Open in new tab